Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Benemei

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Recenti Progressi in Medicina|February 11, 2012
[β-blockers: a new and emerging treatment for melanoma]Vincenzo De Giorgi, Sara Gandini, Marta Grazzini, et al.
Frontiers in Reproductive Health|October 28, 2022
The COVID-19 Pandemic Impact on the Outcome of Medically Assisted Reproduction PregnanciesMor Huri, Virginia Noferi, Irene Renda, et al.
The Journal of Headache and Pain|August 15, 2013
TRPA1 and other TRP channels in migraineSilvia Benemei, Francesco De Cesaris, Camilla Fusi, et al.
Melanoma Research|March 28, 2017
β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-upVincenzo De Giorgi, Marta Grazzini, Silvia Benemei, et al.
Cephalalgia : an International Journal of Headache|July 1, 2022
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraineLuigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, et al.
CNS Drugs|February 11, 2022
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS scoreLuigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
Cephalalgia : an International Journal of Headache|April 20, 2021
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatmentsHeiko Pohl, Silvia Benemei, David Garcia-Azorin, et al.
European Journal of Neurology|January 31, 2022
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraineLuigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
CNS Spectrums|October 29, 2019
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic researchFiammetta Cosci, Andrea Svicher, Sara Romanazzo, et al.
Archives of Internal Medicine|April 27, 2011
Treatment with β-blockers and reduced disease progression in patients with thick melanomaVincenzo De Giorgi, Marta Grazzini, Sara Gandini, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Recenti Progressi in Medicina|February 11, 2012
[β-blockers: a new and emerging treatment for melanoma]Vincenzo De Giorgi, Sara Gandini, Marta Grazzini, et al.
Frontiers in Reproductive Health|October 28, 2022
The COVID-19 Pandemic Impact on the Outcome of Medically Assisted Reproduction PregnanciesMor Huri, Virginia Noferi, Irene Renda, et al.
The Journal of Headache and Pain|August 15, 2013
TRPA1 and other TRP channels in migraineSilvia Benemei, Francesco De Cesaris, Camilla Fusi, et al.
Melanoma Research|March 28, 2017
β-Blocker use and reduced disease progression in patients with thick melanoma: 8 years of follow-upVincenzo De Giorgi, Marta Grazzini, Silvia Benemei, et al.
Cephalalgia : an International Journal of Headache|July 1, 2022
Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraineLuigi Francesco Iannone, Francesco De Cesaris, Anita Ferrari, et al.
CNS Drugs|February 11, 2022
Long-Term Effectiveness of Three Anti-CGRP Monoclonal Antibodies in Resistant Chronic Migraine Patients Based on the MIDAS scoreLuigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
Cephalalgia : an International Journal of Headache|April 20, 2021
Time lost due to an attack - a novel patient-reported outcome measure for acute migraine treatmentsHeiko Pohl, Silvia Benemei, David Garcia-Azorin, et al.
European Journal of Neurology|January 31, 2022
Predictors of sustained response and effects of the discontinuation of anti-calcitonin gene related peptide antibodies and reinitiation in resistant chronic migraineLuigi Francesco Iannone, Davide Fattori, Silvia Benemei, et al.
CNS Spectrums|October 29, 2019
Criterion-related validity in a sample of migraine outpatients: the diagnostic criteria for psychosomatic researchFiammetta Cosci, Andrea Svicher, Sara Romanazzo, et al.
Archives of Internal Medicine|April 27, 2011
Treatment with β-blockers and reduced disease progression in patients with thick melanomaVincenzo De Giorgi, Marta Grazzini, Sara Gandini, et al.
Pageof 10